NCT07591584

A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-05-04Est. Completion: 2026-10-26

Enrollment target: 150 participants

Locations

Contact

Functional Gastrointestinal Disorders (FGID)

Brief Summary Functional gastrointestinal disorders (FGID), including irritable bowel syndrome (IBS), are common condit…

Multiple LocationsEst. completion Sep 1, 2027

Irritable Bowel Syndrome (IBS)

To explore the efficacy of pregabalin for patients with irritable bowel syndrome (IBS).

Beijing, ChinaEst. completion Apr 8, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.